Skip to main content
. 2021 Oct 28;54(7):1591–1601. doi: 10.1007/s11255-021-03036-w

Table 6.

Recovery of kidney function

Variable Recovery (complete/incomplete) No recovery p value
Gender (females in %) 37.2/45.5 37.2 0.56
Age (mean years) 77.6 ± 0.9/79.2 ± 1.1 78.2 ± 1.4 0.55
In-hospital stay (mean days) 19.6 ± 1.2/17.8 ± 1.2 9.6 ± 0.9 < 0.001
AKIN stage (1/2/3 in %) 76.7/18.6/4.7 and 63.6/20/16.4 61.4/19.3/19.3 0.07
Initial eGFR (ml/min) 41.3 ± 2.2/47.1 ± 2.7 43.8 ± 2.4 0.2
Minimal eGFR (ml/min) 25.6 ± 1.3/24.4 ± 1.5 23.8 ± 1.6 0.55
eGFR at demission (ml/min) 51.1 ± 2.4/33.6 ± 2 24.7 ± 1.7 < 0.001
Dialysis (%) 4.7/10.9 15.8 0.08
Initial sodium (mMol/L) 137.3 ± 0.56/138 ± 0.76 138 ± 0.64 0.26
Sodium at AKI onset (mMol/L) 138.6 ± 0.6/138.6 ± 0.6 139.2 ± 0.72 0.41
Initial potassium (mMol/L) 4.4 ± 0.08/4.3 ± 0.08 4.5 ± 0.09 0.18
Potassium at AKI onset (mMol/L) 4.4 ± 0.08/4.3 ± 0.09 4.6 ± 0.1 0.056
Initial CRP (mg/L) 36 ± 6.1/35.7 ± 6.6 36.4 ± 8.3 0.59
Peak CRP (mg/L) 106.7 ± 10.1/82.2 ± 9.5 100.1 ± 12.4 0.47
NT-proBNP (pg/mL) 11,867 ± 1,368/10,514 ± 1,678 14,328 ± 1,961 0.23
Vasopressors (%) 20.9/16.4 36.8 0.026
Ventilation (no/non-invasive/invasive in %) 76.7/16.3/7 and 85.5/10.9/3.6 71.9/10.5/17.5 0.07
ICU treatment (no/1–3/4–10/ > 10 days in %) 70.9/7/12.8/9.3 and 83.6/9.1/3.6/3.6 68.4/17.5/10.5/3.5 0.1
Coronary angiography (no/before/after AKI onset in %) 74.4/7/18.6 and 74.5/10.9/14.5 70.2/24.6/5.3 0.01
Hypertension (%) 90.6/88.9 85.7 0.6
Diabetes (no/non-insulin-dependent/insulin-dependent in %) 45.3/12.8/41.9 and 47.3/18.2/34.5 46.4/12.5/41.1 0.8
Pre-existing CKD (%) 65.1/63.6 64.3 0.9
Pre-existing CHF (%) 57.1/54.5 57.1 0.9
Pre-existing CAD (%) 54.7/50.9 47.4 0.69
Obesity (%) 48.2/40 56.1 0.23
BMI (mean in mg/qm) 29.7 ± 0.8/32.3 ± 1 28.9 ± 2 0.1
Hyperuricemia (%) 23.5/20 25 0.81
Neoplasia (%) 23.8/23.6 30.4 0.63

Results are either shown as mean ± SEM or as percentages

Statistically significant p values are in bold (p < 0.05)